Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Revenue (2020 - 2025)

Pulse Biosciences has reported Revenue over the past 4 years, most recently at $86000.0 for Q3 2025.

  • Quarterly results put Revenue at $86000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $86000.0 (changed N/A YoY), and the annual figure for FY2022 was $700000.0, down 50.0%.
  • Revenue for Q3 2025 was $86000.0 at Pulse Biosciences, down from $300000.0 in the prior quarter.
  • Over the last five years, Revenue for PLSE hit a ceiling of $826000.0 in Q4 2021 and a floor of -$517000.0 in Q2 2021.
  • Median Revenue over the past 3 years was $300000.0 (2022), compared with a mean of $222142.9.
  • Peak annual rise in Revenue hit 13666.67% in 2021, while the deepest fall reached 2561.9% in 2021.
  • Pulse Biosciences' Revenue stood at $826000.0 in 2021, then plummeted by 63.68% to $300000.0 in 2022, then crashed by 71.33% to $86000.0 in 2025.
  • The last three reported values for Revenue were $86000.0 (Q3 2025), $300000.0 (Q2 2022), and $400000.0 (Q1 2022) per Business Quant data.